Healthcare Stocks


Healthcare Stocks Sector

For the past several years, healthcare has been a hot topic of debate. Regardless of whether or not you agree with the Affordable Care Act, your opinion should hold little say in how you play the healthcare stocks in the near future. Despite the controversy over Obamacare, healthcare stocks are playing out to be excellent investments.
With medicine advancing at an astronomical pace, there are many ways to play healthcare stocks. The first way is to invest in the well-known companies like Johnson & Johnson (NYSE:JNJ) which provide a stable investment with decent growth and consistent dividends. The next way to play healthcare stocks is through stocks which offer high potential like Illumina (NADAQ:ILMN), a company that researches genetic functioning. Finally, ETFs like Health Care SPDR (NYSEARCA:XLV) and mutual funds like Fidelity Select Health Care (MUTF:FSPHX) offer limited exposure while still being involved in healthcare.

Healthcare Sector Quote (CIX: MSECTOR5)

10 Game-Changing Health Care Stocks to Buy

By Hilary Kramer, Editor, GameChangers
These 10 diverse stocks are likely to improve their earnings and stock prices in 2012. Take a look.

3 Health Care Stocks in Tip-Top Shape, Poised for Growth

By Louis Navellier, Editor, Growth Investor
Baby boomers are retiring. This, coupled with the beginning of cold and flu season, makes now the perfect time to start thinking about health care stocks.

7 ‘Baby’ Booming Health Care Stocks to Buy Now

By Louis Navellier, Editor, Growth Investor
Health care spending is expected to skyrocket thanks to the aging baby boomers. It’s no wonder stocks like ABC are doing so well. Buy them now.

Aetna Looking a Bit Peaked

By John Kmiecik, InvestorPlace Contributor
When you come across a stock that is trading in a channel, you have plenty of “options” when it comes to finding a strategy that…

Bio-Rad Shares Make the Grade Over Alere

By Will Ashworth, InvestorPlace Contributor
The medical testing sector is booming, but Bio-Rad has shown the ability to consistently generate profit.

7 Health Care Merger Plays

By Nancy Zambell, InvestorPlace Contributor
Here's how to play the feverish pace of M&A in the hospital sector, as big health care providers compete to get much bigger.

Why Dentsply Is a Stock to Buy

By Jon Markman, Editor, Trader's Advantage and CounterPoint Options
The global dental products powerhouse Dentsply (XRAY) looks set to break higher.

How to Cash In on 7 Billion Humans

By Tom Taulli, InvestorPlace Contributor
More people means more demand for resources and services -- it's that simple. Here are seven stocks that stand to benefit.

9 Recession-Proof Biotech Stocks To Cure What Ails You

By Louis Navellier, Editor, Growth Investor
Health care stocks stay firm during a down economy and investors should consider up-and-coming biotech stocks like Alexion, Alkermes, Biogen and Cepheid.

Cigna Deal Signals More Insurance Buyouts to Come

By Barry Cohen, Health Care Writer
Smaller insurers are catching attention in the wake of expected consolidation.

Is Abbott’s Spinoff the Beginning of a Trend?

By Barry Cohen, Health Care Writer
A look at Abbott Labs' (ABT) breakup indicates splitting up may be good medicine for other diversified health care companies.

Heed the Red Flags at Amedisys

By Barry Cohen, Health Care Writer
Congressional scrutiny of home health care specialist Amedisys, along with lowered guidance, are sure-fire signs that investors should proceed with care.

3 Winners to Expect This Earnings Season

By Louis Navellier, Editor, Growth Investor
Earnings season has begun -- and these three highly-rated stocks are expected to hit it out of the park.

Study Results Boost Analyst’s Forecast for Novartis Drug

By Barry Cohen, Health Care Writer
An analyst boosts his forecast for Novartis' Afinitor based on its promise as a treatment for breast cancer.

Express Scripts-Medco Merger Still Looks Like a Go

By Barry Cohen, Health Care Writer
Consumer groups and Big Pharma don’t like it, but the FTC still is likely to OK the Medco-Express Scripts merger.

Go Long Humana at $80

By Serge Berger, InvestorPlace Contributor
A close above this level would be a solid place to enter a long-side trade in Humana Inc.

Allscripts Bought Its Way Into Trouble

By Will Ashworth, InvestorPlace Contributor
MDRX paid too much to acquire Eclipsys, and the all-stock deal it made will come back to haunt it.

New CEO Tasked with Getting Hospira Back on Track

By Barry Cohen, Health Care Writer
Priorities for Hospira's new CEO include fixing manufacturing problems, launching biosimilars in the U.S.

What Ails UnitedHealth

By Will Ashworth, InvestorPlace Contributor
Share repurchases, meager dividends, low margins and pending regulations cloud prospects for UnitedHealth Group's stock.
Load More